Dexyane Anti-Scratching Emollient Cream

The single most frustrating thing about managing eczema — whether your own or your child's — is the way the scratch cycle sabotages everything else you're trying to do. You apply a barrier cream. It helps for forty minutes. Then the itch comes back, the scratching resumes, the barrier breaks down again, and the cream you applied may as well have been water. Most eczema products on the shelf are designed as barrier repair creams: ceramides, fatty acids, maybe some niacinamide, usually shea butter. They assume the limiting factor is barrier damage. But for anyone whose eczema is driven as much by the itch-scratch loop as by underlying xerosis, barrier repair alone isn't enough. What you actually need is something that interrupts the itch signal long enough for the barrier work to matter.

That's the specific gap Ducray's formulators were solving when they developed the Dexyane Anti-Scratching Emollient Cream, and it's the reason this particular product belongs on the short list of genuinely differentiated eczema creams. The usual emollient base is all there: glycerin, shea butter, caprylic/capric triglyceride, dimethicone for a breathable occlusive layer, niacinamide for barrier signaling, allantoin for gentle soothing. But sitting on top of that base are two ingredients you don't see in most competing products. The first is enoxolone — glycyrrhetinic acid from licorice root — which has a reasonably well-studied anti-inflammatory effect, particularly on histamine-driven itch pathways. The second is sucralfate, a sucrose-aluminum complex that's used in gastroenterology to protect ulcerated stomach linings and, applied topically, creates a similar protective layer over the micro-fissures that scratching leaves in eczema-affected skin. Sucralfate in a topical skincare product is unusual enough that it's worth pausing on. It's the kind of inclusion that tells you Pierre Fabre's scientists were thinking about this product as a medical adjunct, not just a moisturizer.

In hand, the cream is rich but not heavy — a matte-white, cushiony texture that absorbs in about a minute without leaving a greasy film. The scent is essentially nothing, which matters because fragrance is one of the most common eczema triggers. The pH sits in the mid-5 range, aligned with healthy skin. It spreads easily across large body areas and doesn't feel sticky in the way some high-shea creams can. You can apply it to the face, though most users reserve it for flare areas rather than daily facial use because the richness is overkill for most facial skin.

The anti-itch effect is the selling point and it's the thing to test first. In most reviewers' experience, itch relief begins within fifteen to thirty minutes of application and meaningfully reduces the urge to scratch for several hours afterward. Overnight, this often translates into the first uninterrupted sleep a flare-affected patient has had in days — which is an effect that's hard to overstate in how much downstream improvement it enables. When patients stop scratching, the barrier gets a chance to repair, the inflammation subsides, and the whole flare tapers faster than it would with barrier repair alone. This is not a placebo-level effect. It's documented in Ducray's tolerance studies and it's consistent with what enoxolone and sucralfate should do mechanically.

The limitations are real and mostly logistical. Availability in the US is poor — Ducray's US distribution has expanded in recent years but it's still primarily a European pharmacy brand, which means finding it often involves specialty online retailers or French pharmacy import sites. The tube packaging, while hygienic, can leak at the seams with heavy squeezing over time. The 200 ml size is the standard option and there's no larger tube, which means body-wide use for severe flare-ups runs through it faster than you'd want. It contains phenoxyethanol as the preservative, which is fine for the vast majority of users but worth flagging for anyone who's been advised to avoid that specific ingredient. And it's not fungal-acne-safe because of the shea butter content, so anyone managing Malassezia folliculitis should approach it cautiously.

Value-wise, at around $28 for 200 ml, it's priced in line with mid-tier European pharmacy creams. Versus a generic barrier-repair moisturizer at $15-20, you're paying the premium specifically for the anti-itch actives. Whether that premium is worth it depends entirely on whether the itch-scratch cycle is actually your bottleneck. For patients whose eczema is mild and mostly dry-skin driven, a cheaper ceramide cream does most of the same barrier work. For patients whose flares are driven by uncontrollable itch, this is one of the most useful topical products available over-the-counter.

The broader context matters too. Ducray has been making dermatology products since 1930 and is part of the Pierre Fabre Dermo-Cosmetique group, which means the Dexyane line isn't a passion project from a new indie brand — it's backed by decades of clinical research and pharmacy-channel distribution across Europe. That's the kind of track record that justifies more confidence in the specific formulation decisions than you'd extend to a newer brand.

Formula

The Science

The underlying evidence here sits in two separate literatures. The first is for enoxolone (glycyrrhetinic acid), a licorice-derived compound with documented anti-inflammatory activity. Published studies, including work in European dermatology journals, have shown enoxolone modulates the inflammatory cascade involved in histamine-driven pruritus and reduces redness in atopic dermatitis models over 2-4 week application windows. The mechanism involves inhibition of 11-beta-hydroxysteroid dehydrogenase, which effectively potentiates the skin's own anti-inflammatory cortisol activity — a clinically relevant pathway that explains why enoxolone feels more potent than its modest ingredient list presence would suggest.

The second literature is for sucralfate, originally developed in the 1960s as a gastric ulcer protectant. Topical sucralfate has been studied in wound healing, radiation dermatitis, and ulcerative conditions, with published work showing that it forms a protective coating over compromised skin that shields it from further irritation while supporting re-epithelialization. Ducray's own tolerance studies on Dexyane, published at European dermatology meetings, have shown reduction in scratching frequency and improvement in tolerance scores in pediatric and adult atopic patients over 28-day use periods.

The strategic point of this formula is that these two actives work on different parts of the itch-scratch cycle — enoxolone dampens the inflammatory signal that produces the itch, while sucralfate physically protects the skin that scratching has damaged. Layered on a niacinamide-and-shea emollient base, this produces a three-pronged effect (anti-itch, protective, barrier-repairing) that's more complete than most ceramide-only eczema creams.

Dermatologist Perspective

Dermatologists who treat atopic dermatitis frequently look for emollients that do more than barrier repair alone, particularly for patients whose flares are driven by uncontrolled itching. This product is commonly recommended by European dermatologists as a flare-phase complement to topical steroid regimens and as a bridge during steroid tapering. Board-certified dermatologists in the US familiar with Pierre Fabre's pharmacy line often recommend it for patients who've exhausted the standard ceramide cream options without adequate itch control. It's also frequently used in pediatric dermatology, where the fragrance-free, pediatric-indicated formulation makes it appropriate for children as young as three months. The unusual inclusion of sucralfate is something dermatologists with a pharmacy background tend to find credible, given sucralfate's long track record in other medical contexts.

Guidance

Ducray's Dexyane line launched in 2014 as Pierre Fabre's clinical response to atopic dermatitis, building on the group's long history of pharmacy-grade dermatology. The Anti-Scratching variant was specifically developed to address the itch-scratch cycle that often undermines otherwise-effective eczema regimens — a recognition that barrier repair alone isn't enough when patients cannot stop scratching.

About Ducray Legacy Brand (20+ years)

Ducray is a French dermatological pharmacy brand founded in 1930 and part of the Pierre Fabre Dermo-Cosmetique group. It has nearly a century of dermatologist and pharmacist distribution in Europe and is backed by the group's substantial clinical research apparatus. Dexyane is its atopic-skin line with published tolerance data.

Brand founded: 1930 · Product launched: 2014

Myth vs. Reality

Myth

Eczema creams shouldn't contain any silicones.

Reality

The dimethicone in this formula is present at a modest level to provide a breathable occlusive film that helps water stay in inflamed skin. It's well-tolerated by atopic skin in published tolerance studies and does not disrupt the barrier.

FAQ

Common Praise

"fast itch relief"

"gentle on inflamed skin"

"cream absorbs well without greasy residue"

"helps break the scratch cycle overnight"

Common Complaints

"hard to find outside European pharmacies"

"not available in larger sizes"

"tube dispenser leaks at seams with heavy use"

Notable Endorsements

French pharmacy staplerecommended by European dermatologists for atopic dermatitis

Appears In

best eczema cream for itching best french pharmacy eczema creams best anti scratching creams best creams for atopic dermatitis best ducray products

Related Conditions

eczema dryness sensitivity compromised skin barrier

Related Ingredients

shea butter niacinamide bisabolol sucralfate